These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6517561)

  • 1. In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).
    Prabhala RH; Rao B; Marshall R; Bansal MB; Thadepalli H
    Antimicrob Agents Chemother; 1984 Nov; 26(5):785-6. PubMed ID: 6517561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is ciprofloxacin active against clinically important anaerobes?
    Watt B; Brown FV
    J Antimicrob Chemother; 1986 May; 17(5):605-13. PubMed ID: 2941400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
    Borobio MV; Perea EJ
    Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.
    Prabhala RH; Thadepalli H; Rao B; Bansal MB; Marshall R
    Antimicrob Agents Chemother; 1985 Apr; 27(4):640-2. PubMed ID: 4004195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Aldridge KE
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1671-4. PubMed ID: 7979307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1984 Mar; 25(3):319-26. PubMed ID: 6232895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of BAY 12-8039, a new fluoroquinolone.
    Woodcock JM; Andrews JM; Boswell FJ; Brenwald NP; Wise R
    Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of three of the newer quinolones against anaerobic bacteria.
    Wexler HM; Molitoris E; Finegold SM
    Antimicrob Agents Chemother; 1992 Jan; 36(1):239-43. PubMed ID: 1317149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of ciprofloxacin against anaerobic bacteria.
    Sutter VL; Kwok YY; Bulkacz J
    Antimicrob Agents Chemother; 1985 Mar; 27(3):427-8. PubMed ID: 3158278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.
    Shafran SD; Wong J; Chow AW
    Antimicrob Agents Chemother; 1985 May; 27(5):749-52. PubMed ID: 4015069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
    Citron DM; Appleman MD
    Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2599-604. PubMed ID: 7872754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
    Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial spectrum of Win 49375.
    Jacobus NV; Tally FP; Barza M
    Antimicrob Agents Chemother; 1984 Jul; 26(1):104-7. PubMed ID: 6476813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.
    Ackermann G; Schaumann R; Pless B; Claros MC; Goldstein EJ; Rodloff AC
    Eur J Clin Microbiol Infect Dis; 2000 Mar; 19(3):228-32. PubMed ID: 10795599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study in vitro on the activity of 7 antibiotics against anaerobic bacteria from hospital isolates].
    Braga A; Bernieri F; Mandelli M; Mosconi P; Rossi A
    Boll Ist Sieroter Milan; 1985; 64(4):294-301. PubMed ID: 4074510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ciprofloxacin (Bay o 9867).
    Fass RJ
    Antimicrob Agents Chemother; 1983 Oct; 24(4):568-74. PubMed ID: 6228192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of Bay Y3118 against anaerobic bacteria.
    Wexler HM; Molitoris E; Finegold SM
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2509-13. PubMed ID: 8285647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.